NCT00942266 Vorinostat, Fluorouracil, and Leucovorin Calcium in Treating Patients With Metastatic Colorectal Cancer That Has Not Responded to Previous Treatment Status COMPLETED Phase PHASE2
NCT00941603 Phase 2 Dose-Ranging Efficacy and Safety Trial of SCH 900271 in Participants With Primary Hypercholesterolemia or Mixed Hyperlipidemia (P05675) Status COMPLETED Phase PHASE2
NCT00939991 Suberoylanilide Hydroxamic Acid (SAHA), Bevacizumab, Daily Temozolomide for Recurrent Malignant Gliomas Status COMPLETED Phase PHASE1/PHASE2
NCT00939952 Ertapenem Pharmacokinetics in Patients in Continuous Ambulatory Peritoneal Dialysis Status COMPLETED Phase PHASE4
NCT00939874 Switch From Tenofovir to Raltegravir for Low Bone Mineral Density Status COMPLETED Phase PHASE4
NCT00937547 Human Papillomavirus Infection and Virus Genotyping in Uterine Cervix Cancer in Venezuela Status COMPLETED Phase N/A
NCT00936195 Universal Use of EFV-TDF-FTC and AZT-3TC-LPV/r Combinations for HIV-1 PMTCT in Pregnant and Breastfeeding Women : a Phase 3 Trial Status WITHDRAWN Phase PHASE3
NCT00935480 IntensVIH: Impact Of Therapy Intensification By An Integrase Inhibitor +/- CCR5 Inhibitor On The Lymphoid Reservoir For Hiv-1 In Chronically Infected Patients Status COMPLETED Phase PHASE3
NCT00935259 Lipid Biomarker Study in Men With Dyslipidemia After Simvastatin Treatment (Study MK-0000-140)(COMPLETED) Status COMPLETED Phase PHASE1
NCT00934466 Study of the Effect of Single Doses of MK2637 and Dextromethorphan on Cerebral Cortex Excitability (2637-008) Status COMPLETED Phase PHASE1
NCT00932009 Prevalence and Type Distribution of Human Papillomavirus (HPV) in Tanzanian Men Status COMPLETED Phase N/A
NCT00931801 BATAR: Individuals Currently Taking Boosted Atazanavir as Part of an HIV Treatment Regimen Will be Evaluated to See if Substituting Raltegravir for Nucleoside Transcriptase Inhibitors Will be Safe and Well Tolerated. Status COMPLETED Phase PHASE4
NCT00931606 Study of Sotatercept for the Treatment of Chemotherapy Induced Anemia in Patients With Metastatic Breast Cancer (MK-7962-012) Status TERMINATED Phase PHASE2
NCT00931463 A Trial of 2 Options for Second Line Combination Antiretroviral Therapy Following Virological Failure of a Standard Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)+2N(t)RTI First Line Regimen Status COMPLETED Phase PHASE4
NCT00927004 Efficacy of Etoricoxib 60 mg in Modifying Pain Hypersensitivity in People With Knee Osteoarthritis Status COMPLETED Phase PHASE4